A carregar...
Validation of commercially available ELISAs for the detection of circulating sclerostin in hemodialysis patients
BACKGROUND: Sclerostin is an endocrine regulator in chronic kidney disease – mineral and bone disorder (CKD-MBD). Validation of assay comparability and pre-analytical handling is mandatory for establishment of sclerostin as a biomarker. METHODS: Blood samples (serum, EDTA, heparin and citrate plasma...
Na minha lista:
| Publicado no: | Discoveries (Craiova) |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4829955/ https://ncbi.nlm.nih.gov/pubmed/27088126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15190/d.2016.2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|